Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholinergic receptors in cognitive disorders.

E K Perry, R H Perry, C J Smith

    The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
    |November 1, 1986
    PubMed
    Summary

    This study examined cholinergic receptors in dementia patients. Alzheimer's disease showed reduced nicotinic receptor binding and a novel inhibitor decrease, suggesting new diagnostic and therapeutic targets.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Placement of dementia sufferers in residential and nursing home care.

    Age and ageing·2005
    Same author

    A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.

    Journal of neurology, neurosurgery, and psychiatry·2005
    Same author

    Interleukin-6 and acute ischaemic stroke.

    Acta neurologica Scandinavica·2005
    Same author

    Genetic and structural analysis of the Bacteroides conjugative transposon CTn341.

    Journal of bacteriology·2005
    Same author

    Late aortic root dilatation in tetralogy of Fallot may be prevented by early repair in infancy.

    Pediatric cardiology·2005
    Same author

    Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.

    Thorax·2004

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Neuropathology

    Background:

    • Cholinergic system alterations are implicated in cognitive disorders.
    • Hippocampal cholinergic receptor subtypes (muscarinic M1, M2, and nicotinic) are crucial for memory and cognition.

    Purpose of the Study:

    • To investigate changes in muscarinic and nicotinic receptor binding in the hippocampus of patients with various cognitive disorders.
    • To compare these changes with neurologically normal controls and Motor Neuron disease cases.
    • To identify potential diagnostic markers and therapeutic targets for Alzheimer's disease.

    Main Methods:

    • Autopsy-obtained hippocampal tissue from patients with Alzheimer's disease, Parkinson's disease, Huntington's disease, Down's Syndrome, alcoholic dementia, Motor Neuron disease, and controls.

    Related Experiment Videos

  • Radioligand binding assays to quantify muscarinic (M1, M2) and nicotinic receptor binding.
  • Measurement of choline acetyltransferase (ChAT) activity to assess presynaptic cholinergic deficit.

    • Main Results:

    • Substantial reduction in nicotinic receptor binding in disorders with presynaptic cholinergic deficit (Alzheimer's, Parkinson's, Down's Syndrome).
    • Moderate reduction in M1 and M2 muscarinic receptor binding in Alzheimer's disease.
    • Significantly increased nicotinic receptor binding in non-demented Parkinson's disease cases.
    • Decreased endogenous inhibitor of nicotinic binding observed uniquely in Alzheimer's disease.

    Conclusions:

    • Alzheimer's disease exhibits significant alterations in both muscarinic and nicotinic cholinergic systems.
    • Nicotinic receptor dysfunction and a potential endogenous modulator abnormality are key features of Alzheimer's disease.
    • Targeting both muscarinic and nicotinic receptors may offer therapeutic and diagnostic avenues for Alzheimer's disease.